foxo4 dri senolytic peptide human trials Buy FOXO4-DRI 10mg | Third-Party Tested Buy FOXO4-DRI 10mg Peptide |

INCI Nomenclature: Water, Copper peptide (GHK-Cu), Lactobacillus Ferment

GH increased 210 , IGF-I increased ~1.53 after a single dose in trials

In further embodiments, the invention encompasses a method of providing muscular therapy by contacting a cell expressing NNMT with one or more cations of the invention and with one or more cations chosen from Tables 3a and 3b

GH peak/insulin-like growth factor-1 (IGF-1) were also significantly reduced in severe ME/CFS patients compared to controls and ME/CFS patients with mild disease

The benefits of TB-4 and BPC 157 generally arise from the fact that these two peptides affect the same cells in slightly different ways